MarketPeel
Insider Trading Intelligence
Pricing
…
MR

Matthew E. Ros

JSPR
CHIEF OPERATING OFFICER · JASPER THERAPEUTICS, INC. · CIK 0001461613
FILING MIX · LIFETIME100%/0%
BUYS
1
SELLS
0
TOTAL VALUE
$0
COMPANIES
1
ACTIVE SINCE
Jul 2026
HOLDINGS NOW
881
AVG SELL PX
—
TRADE KIND
SHOWING 1 / 1
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
No backtest data available for Matthew E. Ros. Backtests are computed for purchase (P) and sale (S) transactions with resolvable price history.
Holdings over time
Not enough transaction history to chart holdings.
Trading cadence · quarterly flow
BUY ● SELL ●
2026
FLOW · 1 buys / 0 sellsCOVERAGE · 1 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
JSPR
JASPER THERAPEUTICS, INC.
PURCHASE
Chief Operating Officer
881——881Jul 20, 2026Jul 22, 2026 ↗View →
Other insiders · JSPR
Loading peer insiders…
About this filer
CIK 0001461613
ROLE
Chief Operating Officer
PRIMARY
JSPR
COMPANIES
1
ACTIVE SINCE
Jul 2026
MARKETPEEL · /INSIDER/0001461613DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback